The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen
- 22 January 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 16 (4), 322-327
- https://doi.org/10.1007/s10147-010-0183-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal CancerEvidence-Based Complementary and Alternative Medicine, 2011
- Effect of calcium and magnesium on neurotoxicity and blood platinum concentrations in patients receiving mFOLFOX6 therapy: a prospective randomized studyInternational Journal of Clinical Oncology, 2010
- Oxaliplatin Acts on IB4-Positive Nociceptors to Induce an Oxidative Stress-Dependent Acute Painful Peripheral NeuropathyThe Journal of Pain, 2008
- Use of Calcium and Magnesium Salts to Reduce Oxaliplatin-Related NeurotoxicityJournal of Clinical Oncology, 2007
- Oral Glutamine Is Effective for Preventing Oxaliplatin-Induced Neuropathy in Colorectal Cancer PatientsThe Oncologist, 2007
- Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomised, controlled, multicenter phase II studyInvestigational New Drugs, 2006
- Phase I Study of Single-Dose Oxaliplatin in Japanese Patients with Malignant TumorsJapanese Journal of Clinical Oncology, 2006
- N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary dataSupportive Care in Cancer, 2006
- Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium InfusionsClinical Cancer Research, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000